AF
ASMB icon

Allworth Financial’s Assembly Biosciences ASMB Stock Holding History

Allworth Financial’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275 Sell
10
-19
-66% -$517 ﹤0.01% 4922
2026
Q1 		$805 Sell
29
-3
-9% -$86 ﹤0.01% 4627
2025
Q4 		$1.09K Buy
+32
New +$1.03K ﹤0.01% 4330

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Allworth Financial's ASMB Position: Q2 2026 in Review

Allworth Financial reduced its Assembly Biosciences (ASMB) stake by 66% in Q2 2026, selling an estimated $517 and leaving 10 shares worth $275. The position accounts for ﹤0.01% of the portfolio, ranked #4922.

Allworth Financial first reported a position in ASMB in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.09K in Q4 2025. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Allworth Financial held 10 shares of Assembly Biosciences worth $275 as of Q2 2026.
  • Allworth Financial sold 19 Assembly Biosciences shares in Q2 2026, an estimated $517.
  • Assembly Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4922 holding.
  • Allworth Financial first reported a position in Assembly Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Allworth Financial's Assembly Biosciences position peaked at $1.09K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.